Cargando…
SIA-IgG confers poor prognosis and represents a novel therapeutic target in breast cancer
The incidence rate of breast cancer is the highest in the world, and major problem in the clinical treatment is the therapy resistance of breast cancer stem cells (CSCs). Thus, new therapeutic approaches targeting breast CSCs are needed. Our previous study demonstrated cancer-derived sialylated IgG...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208471/ https://www.ncbi.nlm.nih.gov/pubmed/35473571 http://dx.doi.org/10.1080/21655979.2022.2063593 |